Frequently Asked Questions
Common Questions About Using ICD-10 Code F18.27 for Inhalant dependence with inhalant-induced dementia
What are the primary symptoms of inhalant dependence with inhalant-induced dementia?
Primary symptoms include cognitive impairment, memory loss, behavioral changes, and physical coordination issues. Patients may also exhibit mood swings and social withdrawal.
How is inhalant dependence with inhalant-induced dementia treated?
Treatment typically involves cognitive rehabilitation, psychosocial support, and monitoring of cognitive function. In some cases, pharmacologic interventions may be necessary for associated mental health issues.
When should ICD-10 Code F18.27 be used?
This code should be used when a patient presents with inhalant dependence that has resulted in cognitive impairment, as documented through clinical assessments and patient history.
Can inhalant dependence lead to long-term cognitive issues?
Yes, chronic inhalant use can lead to persistent cognitive deficits and behavioral changes, necessitating ongoing treatment and support.
